(PharmaNewsWire.Com, May 05, 2017 ) Publisher's market research analyst predicts that the global left atrial appendage closure market will grow at a CAGR of approximately 28% by 2020. The recent increase in new product approvals by regulating bodies such as the FDA is one of the major reasons for the rising market demand. The growing focus on clinical trials by vendors that results in increased number of new product approvals and launches is also expected to augment market growth. Increasing incidences of stroke among the populace is the key driver for the growth of this market. Stroke is a medical condition that is common in people suffering from diabetes and cardiovascular diseases. The ability of left atrial appendage (LAA) closure devices to close off the LAA, so as to reduce the risk of stroke is a critical factor that impels the adoption of such devices during the predicted period.
Geographical segmentation of the left atrial appendage closure market - Americas - APAC - EMEA
Publisher market research analysts estimate the EMEA region to be the largest market for LAA closure devices during the forecast period. The recent increase in the incidence of stroke coupled with the growing elderly population in this region is a significant factor that fosters market growth during the forecast period. Product-based segmentation of the left atrial appendage closure market - Epicardial LAA closure device - Endocardial LAA closure device The epicardial LAA closure devices segment involves percutaneous closed-chest epicardial LAA ligation and offers advantages like short-term systemic anticoagulation. The ability of such devices to avoid post-implantation procedures is a major factor that augments its adoption during the forecast period.
Competitive landscape and key vendors The global LAA closure market is competitive and is primarily dominated by vendors like Atricure and Boston Scientific. Since this market is consolidated, only a few vendors that have the ability to provide products to the international market can survive and succeed during the forecast period. The leading vendors in the market are - - Boston Scientific - St. Jude Medical - AtriCure - Coherex Medical
Other prominent vendors in the market include Lifetech Scientific, SentreHEART, Occlutech and Lifetech Scientific
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
